Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of agomelatine on delirium rate
IRCT20220508054780N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of agomelatine in delirium, sponsored by Mashhad University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
agomelatine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20220508054780N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220508054780N4.